FDA Warning Letter Review Suggests Aggressive Action Needed, Troy Says

FDA Office of Chief Counsel's review of warning and untitled letters suggests that the agency should be taking more aggressive enforcement actions, Chief Counsel Daniel Troy suggested Feb. 21